João Herminio Martins Da Silva (João Herminio Martins-Da-Silva, João Hermínio Martins da Silva)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Angiotensin Converting Enzyme

Inflammatory Response

Molecular Dynamics

Top Venues

Journal of chemical information and modeling

Journal of biomolecular structure & dynamics

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Andrade, Aline Albuquerque, Andrielly Santos-Costa, Disraeli Vasconcelos, Wilson Savino, Geraldo Rodrigues Sartori, João Herminio Martins Da Silva
Investigation of Unprecedented Sites and Proposition of New Ligands for Programmed Cell Death Protein I through Molecular Dynamics with Probes and Virtual Screening. Journal of chemical information and modeling 62 (5) (2022)
Melina Mottin, Bruna Katiele de Paula Sousa, Nathalya Cristina de Moraes Roso Mesquita, Ketllyn Irene Zagato de Oliveira, Gabriela Dias Noske, Geraldo Rodrigues Sartori, Aline de Oliveira Albuquerque, Fabio Urbina, Ana C Puhl, José Teófilo Moreira-Filho, Guilherme Eduardo de Souza, Rafael V C Guido, Eugene N Muratov, Bruno Junior Neves, João Herminio Martins Da Silva, Alex E Clark, Jair L Siqueira-Neto, Alexander L Perryman, Glaucius Oliva, Sean Ekins, Carolina Horta Andrade
Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika. Journal of chemical information and modeling (2022)
Disraeli Vasconcelos, Beatriz Chaves, Aline Albuquerque, Luca Andrade, Andrielly Henriques, Geraldo Rodrigues Sartori, Wilson Savino, Ernesto Raul Caffarena, João Herminio Martins Da Silva
Development of New Potential Inhibitors of β1 Integrins through In Silico Methods-Screening and Computational Validation. Life (Basel, Switzerland) 12 (7) (2022)
Aline de Oliveira Albuquerque, Haroldo Cid da Silva Junior, Geraldo Rodrigues Sartori, João Herminio Martins Da Silva
Computationally-obtained structural insights into the molecular interactions between Pidilizumab and binding partners DLL1 and PD-1. Journal of biomolecular structure & dynamics (2021)